Fundz

EQT bids EUR 10.8bn for Qiagen

PUBLIC · EQTOct 21, 2026

Acquiring Company

EQT AB

Acquired Company

QIAGEN

OtherEnergyOil And GasFinancial ServicesSoftwarePaymentsFinanceVenture CapitalAngel InvestmentBiotechnologyHealth CareScience And EngineeringInternet Services

Description

EQT AB confirmed a recommended cash bid of EUR 46.50 per Qiagen share, valuing the deal at EUR 10.8 billion, on October 21, 2026. The offer carries a 40.30 percent premium to Qiagen's unaffected Xetra close on July 8, 2026. The bid expands EQT's healthcare exposure and adds a second major transaction to its expansion plans.

Who to call at EQT AB, and when

When EQT AB changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day EQT AB raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at EQT AB, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

EQT AB

Location

Liberty Avenue

About

EQT AB is an international purpose-driven investment organization. It is the parent company of BPEA Private Equity Fund VIII ('EQT Ásia') and is known for its strategic investments and acquisitions in various industries. EQT is focused on creating sustainable value and driving growth in its portfolio companies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment EQT AB makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Rene
Senior decision-maker at this company
••••••••@••••••••

See Rene's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for EQT AB's next move

Learn about Strategic plan

Frequently asked

Who acquired QIAGEN?

QIAGEN was acquired by EQT AB. The deal was reported on October 21, 2026. EQT AB is an international purpose-driven investment organization. EQT AB is publicly traded (EQT) and operates in Other.

When did EQT AB acquire QIAGEN?

EQT AB's acquisition of QIAGEN was reported on October 21, 2026. EQT AB confirmed a recommended cash bid of EUR 46.50 per Qiagen share, valuing the deal at EUR 10.8 billion, on October 21, 2026. The offer carries a 40.30 percent premium to Qiagen's unaffected Xetra close on July 8, 2026. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does QIAGEN do?

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. It is privately held, operating in Biotechnology.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.